about
Akt binds to and phosphorylates phospholipase C-gamma1 in response to epidermal growth factorA novel regulatory mechanism links PLCγ1 to PDK1Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migrationEnzyme-responsive nanomaterials for controlled drug deliverySchwann cells induce cancer cell dispersion and invasion.Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Spatio-temporal modeling of signaling protein recruitment to EGFR.Integrated analysis of copy number variation and genome-wide expression profiling in colorectal cancer tissuesHIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia.Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway.Cross-talk between phospho-STAT3 and PLCγ1 plays a critical role in colorectal tumorigenesis.Intramolecular regulation of phospholipase C-gamma1 by its C-terminal Src homology 2 domain.Si Shen Wan Regulates Phospholipase Cγ-1 and PI3K/Akt Signal in Colonic Mucosa from Rats with Colitis.A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylationDAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia.Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative.Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.ErbB receptors in the biology and pathology of the aerodigestive tractMR evaluation of response to targeted treatment in cancer cells.Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy.Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.Should I stay or should I go? Shedding of RPTPs in cancer cells switches signals from stabilizing cell-cell adhesion to driving cell migration.Stimuli-responsive polymersomes for cancer therapy.The role of phospholipase Cγ1 in breast cancer and its clinical significance.Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.PLC-gamma1 regulates fibronectin assembly and cell aggregation.Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions.ErbB Receptors and Cancer.Some Biological Consequences of the Inhibition of Na,K-ATPase by Translationally Controlled Tumor Protein (TCTP).
P2860
Q24306906-0E4F4340-15F3-4661-B610-D9DD8FAFCF93Q24310088-16370E74-C056-4A45-BC97-9141563C2AA1Q24632320-C6B9C4DD-FB10-4F9C-82C4-2FBC874244D9Q26992127-17E12546-6D08-4072-99FC-9A4A1C3B5088Q27331510-971FE029-9563-4057-8495-FB64EC6AD7C8Q30361646-6CB5CF27-C6EB-4643-91D1-4D611FA1EEC9Q30982487-92B39A96-4A79-4385-9582-A7785767A87CQ31155184-80CFC469-11CC-4875-80EE-82EC06B52E26Q33947789-6CDA0F07-547E-4826-A284-D1E2BC49499BQ34154752-910F180E-81F5-414E-9143-C06E2B6326CDQ35386200-C26697E8-280D-4291-8E17-D14987BED6A9Q35641775-6200BBA3-5687-4C65-B703-59E31FE9EA68Q35932270-AF55880B-CFFC-4554-AF9F-90E62AFDAA88Q36347241-C7EDEA27-29B3-422D-8C93-164A32876239Q36404038-E2D8F5AE-4177-4513-BDED-C5DC9EEE45EBQ36578001-A68402D4-9024-41A9-8415-00874B45670CQ36671457-721F6E8B-09C8-4A2A-ABE4-5A4B9FF3B6ECQ36946711-512083D4-0977-4F77-B31C-1DAF33EB4F8CQ37111705-4E8873D4-69F6-4F85-B6EB-FDCBCEC5D079Q37263452-F6FEC7DD-935F-417F-A771-DE307C5DC161Q37851076-1F922743-FABC-47E8-AFB3-D778246071A2Q38193533-C9FB583D-E2D1-419D-8EEE-6887CE8CB10DQ38563527-FF883669-5B6A-45ED-B7D5-72E96C2B4BBCQ38568541-7F5859A9-3752-4C4C-A68A-9A1C106BCCFBQ38604606-2F69839C-8A12-45BE-975F-218FCC605B78Q38638852-9299C654-C45A-428F-AA6A-2B3BAF60B329Q39800120-E034FD44-BF1D-4F07-8268-4ED140E7CB85Q40498647-56777727-1182-4038-940E-712460D2711CQ41472008-FA21E2B3-8F98-44F2-B710-0505E7E5940BQ44221566-414116B0-6916-46FE-A294-3E3F51FB6D8FQ47659277-8A55DE33-508F-4D72-8EF7-9DE9ACFD4F17Q47974787-86FB3ECC-AE91-494A-8D62-6350572A2C1AQ55620580-AB256903-665C-49DF-AA07-534B617CB6B4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phospholipase C-gamma1 in tumor progression.
@ast
Phospholipase C-gamma1 in tumor progression.
@en
type
label
Phospholipase C-gamma1 in tumor progression.
@ast
Phospholipase C-gamma1 in tumor progression.
@en
prefLabel
Phospholipase C-gamma1 in tumor progression.
@ast
Phospholipase C-gamma1 in tumor progression.
@en
P356
P1476
Phospholipase C-gamma1 in tumor progression
@en
P2093
Jennifer Rubin Grandis
P2888
P304
P356
10.1023/A:1024088922957
P50
P577
2003-01-01T00:00:00Z
P6179
1036016821